TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/23 21:50 | 12/14/23 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | S.a | -312 | 41.05 | 0 | -8 | -61 | 5 | I | |||||||||||||||
12/15/23 17:38 | 12/13/23 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | M.d | 137 | 9.55 | 0 | 14 | 102 | 28 | M | |||||||||||||||
12/15/23 17:38 | 12/13/23 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | S.d | -759 | 39.99 | 0 | -19 | -40 | 28 | M | |||||||||||||||
11/28/22 20:41 | 11/23/22 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | S.dm | -138 | 34.55 | 0 | -4 | -10 | 36 | D | |||||||||||||||
11/28/22 20:41 | 11/25/22 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | M.d | 6 | 2.68 | 0 | 2 | 6 | 36 | D | |||||||||||||||
12/10/21 16:20 | 12/8/21 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Patou Gary | A1 | D | M.d | 8 | 3.67 | 0 | 2 | 6 | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |